| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.12B | +1.5% | +4.0% |
| R&D Expense | $18.0M | +5.9% | +12.5% |
| SG&A Expense | $143.0M | +23.3% | +12.6% |
| Operating Income | $110.0M | -8.3% | -7.6% |
| Pre-tax Income | $33.0M | -47.6% | -10.8% |
| Income Tax | $7.0M | -63.2% | -50.0% |
| Net Income | $26.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $412.0M | +15.4% | +4.3% |
| Accounts Receivable | $569.0M | -14.9% | -8.7% |
| Inventory | $383.0M | -4.3% | +9.1% |
| Current Assets | $1.82B | -8.0% | -5.9% |
| Total Assets | $5.65B | -2.8% | -1.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $125.0M | — | — |
| Capital Expenditures | $80.0M | — | — |
| Investing Cash Flow | -$88.0M | — | — |
| Financing Cash Flow | -$102.0M | — | — |
| Free Cash Flow | $45.0M | — | — |
| -42.2% |
| +8.3% |
| EPS (Basic) | $0.35 | -42.6% | +6.1% |
| EPS (Diluted) | $0.34 | -43.3% | +6.3% |
| $1.78B |
| -5.5% |
| -0.8% |
| Long-term Debt | $2.79B | -1.0% | -4.0% |
| Total Liabilities | $5.32B | -2.6% | -3.0% |
| Stockholders' Equity | $330.0M | -5.7% | +25.0% |